P-D-R Pharma Documentation Ring

The P-D-R is an association whose members represent the scientific information departments of the leading international R&D-based pharmaceutical corporations.

Latest News from the P-D-R Company Websites

Published 21 October 2016 | 8:37 pm

U.S. Food and Drug Administration Accepts for Priority Review the Supplemental Biologics License Application for Opdivo (nivolumab) in Previously Treated Patients With Advanced Form of Bladder Cancer

Submission based on results from Phase 2 study CheckMate -275 evaluating Opdivo in patients with previously treated platinum-refractory metastatic urothelial carcinoma more ...

Published 21 October 2016 | 7:49 pm

FDA Approves Supplemental New Drug Application for XTANDI® (enzalutamide) Capsules in Advanced Prostate Cancer

- TERRAIN Trial Showed Improved Radiographic Progression-Free Survival with Enzalutamide Versus Bicalutamide in Men with Metastatic Castration-Resistant Prostate Cancer - more ...

Published 21 October 2016 | 5:15 pm

Bristol-Myers Squibb Updates Conference Call Dial-in/ID for Third Quarter 2016 Results on October 27

NEW YORK--( BUSINESS WIRE )-- Bristol-Myers Squibb Company (NYSE:BMY) will announce results for the third quarter of 2016 on Thursday, October 27, 2016. During a more ...

Published 21 October 2016 | 10:18 am

Three projects win 2016 European PRRS Research Award sponsored by Boehringer Ingelheim Animal Health

Boehringer Ingelheim Animal Health has sponsored European PRRS Research Award for the third time The main aim of the award is to encourage research in the field of PRRS more ...

Published 20 October 2016 | 5:06 pm

Defining the True Value of Innovation in Cancer Treatment

Bristol Myers-Squibb believes the current structure of the Institute for Clinical and Economic Review's (ICER) value assessment model takes a static approach to what is an more ...

Published 20 October 2016 | 4:32 pm

Gilead Announces Top-Line Phase 2 Results for GS-4997 (Selonsertib) in Nonalcoholic Steatohepatitis (NASH), Pulmonary Arterial Hypertension (PAH) and Diabetic Kidney Disease (DKD)

-- GS-4997 Demonstrates Anti-Fibrotic Activity in Open-Label Phase 2 NASH Study; Data Support Plans to Advance GS-4997 into Phase 3 Clinical Trials -- more ...

Published 20 October 2016 | 4:24 pm

Press Releases

Home / News / Press Releases / Gilead Announces SVR12 Rates From Four Phase 3 Studies of a Once-Daily, Fixed-Dose Combination of Sofosbuvir, Velpatasvir and more ...

Published 20 October 2016 | 3:39 pm

Advocating For Diversity in Nursing, Baxter-Supported Schweitzer Fellow Inspires First Generation Nursing Students to Pursue Higher Education

As a Chicago-area Schweitzer Fellow, Evelyn created the Leadership, Education and Development program (LEAD) to both increase diversity in the nursing profession and more ...

Published 20 October 2016 | 8:30 am

Osteoporosis fractures: why once is enough

Posted by Scott Fleming, Communications British & Irish Isles more ...

Published 20 October 2016 | 12:19 am

CDC Advisory Committee on Immunization Practices Votes to Recommend New Dosing Schedule for Vaccination with TRUMENBA® (Meningococcal Group B Vaccine)

Recommendation provides updated guidance for administering a two- or a three-dose series more ...

Pharma Documentation Ring:
24 companies - 4 common aims:

  • Promote exchange of experience/networking among members
  • Encourage commercial development of new information services and systems
  • Jointly assess new and existing products and services
  • Provide a forum for the information industry
  • How to become a P-D-R member?
Next Annual General Meeting, Sept 13-16, 2016 – San Francisco

Next Annual General Meeting, Sept 13-16, 2016 – San Francisco